ZYNE
Zynerba Pharmaceuticals, Inc
ZYNE
ZYNE
Delisted
ZYNE was delisted on the 10th of October, 2023.
79 hedge funds and large institutions have $64.8M invested in Zynerba Pharmaceuticals, Inc in 2019 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 29 increasing their positions, 17 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
36% less call options, than puts
Call options by funds: $3.82M | Put options by funds: $5.95M
Holders
79
Holding in Top 10
–
Calls
$3.82M
Puts
$5.95M
Top Buyers
| 1 | +$1.82M | |
| 2 | +$1.61M | |
| 3 | +$1.14M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$1.11M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$527K |
Top Sellers
| 1 | -$3.88M | |
| 2 | -$2.06M | |
| 3 | -$1.46M | |
| 4 |
ARTA
A.R.T. Advisors
New York
|
-$429K |
| 5 |
LPL Financial
San Diego,
California
|
-$351K |